Entering text into the input field will update the search result below

Investors like Acorda's move for Civitas

Sep. 24, 2014 8:51 AM ETAcorda Therapeutics, Inc. (ACOR) StockACORBy: Douglas W. House, SA News Editor
  • Acorda Therapeutics (NASDAQ:ACOR) is up 10% premarket on robust volume in response to its acquisition of Civitas Therapeutics.

Recommended For You

More Trending News

About ACOR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ACOR--
Acorda Therapeutics, Inc.